PE20020055A1 - Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal - Google Patents

Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal

Info

Publication number
PE20020055A1
PE20020055A1 PE2001000462A PE2001000462A PE20020055A1 PE 20020055 A1 PE20020055 A1 PE 20020055A1 PE 2001000462 A PE2001000462 A PE 2001000462A PE 2001000462 A PE2001000462 A PE 2001000462A PE 20020055 A1 PE20020055 A1 PE 20020055A1
Authority
PE
Peru
Prior art keywords
nasal decongestant
stable liquid
solid formulations
formulations including
sedating antihistamine
Prior art date
Application number
PE2001000462A
Other languages
English (en)
Inventor
Lugo Sergio Rolando Ulloa
Ramos Jose De Jesus Villacampa
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MXPA/A/2000/005129A external-priority patent/MXPA00005129A/es
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE20020055A1 publication Critical patent/PE20020055A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: a) DE 0,4mg/ml A 0,7mg/ml DE LORATADINA; b) UN DESCONGESTIONANTE NASAL TAL COMO PSEUDOEFEDRINA, PROPANOLAMINA ; c) UN EXPECTORANTE TAL COMO AMBROXOL Y d) UN VEHICULO FARMACEUTICAMENTE ACEPTABLE. LA COMPOSICION CONTIENE ADEMAS UN AGENTE ANTIMICROBIANO, EDULCORANTE, PROPILENGLICOL Y GLICERINA. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA ESTABLE EN FORMA LIQUIDA QUE COMPRENDE UNA COMBINACION DE: a) UN EDULCORANTE TAL COMO SORBITOL, SACARIDO DE SODIO; b) UN VEHICULO LIQUIDO Y c) UN SISTEMA BUFFER PARA MANTENER EL pH EN EL RANGO DE 3 A 5. LA COMPOSICION ES ESTABLE A LA CONTAMINACION DE MICROORGANISMOS DURANTE PERIODOS DE 4 MESES A 36 MESES A TEMPERATURA AMBIENTE
PE2001000462A 2000-05-25 2001-05-22 Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal PE20020055A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA/A/2000/005129A MXPA00005129A (es) 2000-05-24 Composiciones farmaceuticas antihistaminicas - anticongestivas liquidas estables

Publications (1)

Publication Number Publication Date
PE20020055A1 true PE20020055A1 (es) 2002-02-12

Family

ID=33308448

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000462A PE20020055A1 (es) 2000-05-25 2001-05-22 Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal

Country Status (7)

Country Link
AU (1) AU2001264806A1 (es)
BR (1) BR0111018A (es)
CR (1) CR6804A (es)
EC (1) ECSP024356A (es)
PA (1) PA8517201A1 (es)
PE (1) PE20020055A1 (es)
WO (1) WO2001089527A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635654B1 (en) 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
US8603523B2 (en) * 2005-06-17 2013-12-10 Aft Pharmaceuticals Limited Pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
PE20080994A1 (es) * 2006-06-29 2008-08-06 Schering Corp Jarabes antihistaminicos, estables al almacenamiento sin azucar

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
CA2170488A1 (en) * 1993-09-07 1995-03-16 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
PL333056A1 (en) * 1996-10-31 1999-11-08 Schering Corp Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6051585A (en) * 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
CA2405238C (en) * 2000-04-14 2014-03-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis

Also Published As

Publication number Publication date
PA8517201A1 (es) 2002-08-26
WO2001089527A3 (en) 2003-10-16
AU2001264806A1 (en) 2001-12-03
CR6804A (es) 2008-10-29
WO2001089527A2 (en) 2001-11-29
ECSP024356A (es) 2003-03-31
BR0111018A (pt) 2004-02-17

Similar Documents

Publication Publication Date Title
ES2194732T3 (es) Composiciones farmaceuticas orales de liberacion controlada de mesalazina.
GT200000222A (es) Forma de dosificacion de farmacos accionada por un hidrogel.
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
ES2193726T3 (es) Formulaciones de aerosol medicinales.
ES2176684T3 (es) Nuevas asociaciones de principios activos que contienen clopidogrel y un antitrombotico.
NO20011471D0 (no) Nye orale vedvarende frigivelsesformuleringer
BR9611523A (pt) Meios de administração para drogas analgésicas, antiinflamatórias e antipiréticas contendo óxido nitroso e composições farmacêuticas contendo tais meios e drogas.
AR037255A1 (es) Composiciones farmaceuticas que contienen oxibutinina
CO5170497A1 (es) Formulaciones liquidas estables de toxina botulinica
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
AR035034A1 (es) Composicion farmaceutica liquida
BR9909266A (pt) Formulações efervescentes
ES2197792B1 (es) Formulaciones farmaceuticas que contienen morfina intranasal.
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
PE88699A1 (es) Formas de dosificacion de liberacion sostenida de sertralina
ES2193515T3 (es) Composicion farmaceutica que comprende un compuesto triciclico con mejor estabilidad, absortividad y escaso potencial irritativo.
ITMI20021392A1 (it) Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
ES2104845T3 (es) Composiciones lipofilas de sales de antibioticos oligosacaridos.
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
AR031649A1 (es) Composicion farmaceutica de dronedarona para administracion parenteral
ES2142430T3 (es) Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral.
RS50246B (sr) Tableta za sisanje, koja sadrži ambroksol
PE20020055A1 (es) Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal
CO5550418A2 (es) Formulaciones antihistaminicas para formas de dosificacion de capsula blanda
AR087240A2 (es) Composiciones farmaceuticas que tienen epinastina y pseudoefedrina

Legal Events

Date Code Title Description
FC Refusal